{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T14:35:58Z","timestamp":1776695758020,"version":"3.51.2"},"reference-count":30,"publisher":"Impact Journals, LLC","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2019,7,9]]},"DOI":"10.18632\/oncotarget.27028","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T10:19:41Z","timestamp":1562667581000},"page":"4369-4379","source":"Crossref","is-referenced-by-count":34,"title":["Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS)"],"prefix":"10.18632","volume":"10","author":[{"given":"Goro","family":"Kasuya","sequence":"first","affiliation":[{"name":"QST Hospital (Former Hospital of the National Institute of Radiological Sciences), National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Japan Carbon-Ion Radiation Oncology Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Terashima","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Shibuya","sequence":"additional","affiliation":[{"name":"Gunma University Heavy Ion Medical Center, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Toyama","sequence":"additional","affiliation":[{"name":"Ion Beam Therapy Center, SAGA-HIMAT Foundation, Tosu, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel K.","family":"Ebner","sequence":"additional","affiliation":[{"name":"QST Hospital (Former Hospital of the National Institute of Radiological Sciences), National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan"},{"name":"Harvard TH Chan School of Public Health, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Tsuji","sequence":"additional","affiliation":[{"name":"QST Hospital (Former Hospital of the National Institute of Radiological Sciences), National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Okimoto","sequence":"additional","affiliation":[{"name":"Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Ohno","sequence":"additional","affiliation":[{"name":"Gunma University Heavy Ion Medical Center, Maebashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Shioyama","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kyushu University, Hakata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[{"name":"QST Hospital (Former Hospital of the National Institute of Radiological Sciences), National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kamada","sequence":"additional","affiliation":[{"name":"QST Hospital (Former Hospital of the National Institute of Radiological Sciences), National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2019,7,8]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"VI1","DOI":"10.1136\/gut.51.suppl_6.vi1","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document","volume":"51","author":"Wasan","year":"2002","journal-title":"Gut"},{"key":"2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nrgastro.2011.20","article-title":"Cholangiocarcinoma\u2014controversies and challenges","volume":"8","author":"Patel","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Bridgewater","year":"2010","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/sj.bjc.6605779","article-title":"Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan","volume":"103","author":"Furuse","year":"2010","journal-title":"Br J Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1634\/theoncologist.9-1-43","article-title":"Diagnosis and treatment of cholangiocarcinoma","volume":"9","author":"Chari","year":"2004","journal-title":"Oncologist"},{"key":"6","first-page":"102","article-title":"External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinoma","volume":"62","author":"Huang","year":"2015","journal-title":"Hepatogastroenterology"},{"key":"7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.radonc.2010.03.013","article-title":"Stereotactic fractionated radiotherapy for Klatskin tumours","volume":"95","author":"Becker","year":"2010","journal-title":"Radiother Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.radonc.2011.05.016","article-title":"Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience","volume":"99","author":"Ambrosino","year":"2011","journal-title":"Radiother Oncol"},{"key":"9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00066-018-1367-2","article-title":"Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review","volume":"195","author":"Rim","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2307\/3579446","article-title":"Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy","volume":"147","author":"Ohara","year":"1997","journal-title":"Radiat Res"},{"key":"11","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ijrobp.2005.09.043","article-title":"Examination of GyE system for HIMAC carbon therapy","volume":"64","author":"Tsujii","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"12","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fonc.2016.00140","article-title":"The emerging role of carbon-ion radiotherapy","volume":"6","author":"Kamada","year":"2016","journal-title":"Front Oncol"},{"key":"13","first-page":"2955","article-title":"Initial results of hypofractionated carbon ion radiotherapy for cholangiocarcinoma","volume":"36","author":"Nakano","year":"2016","journal-title":"Anticancer Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1002\/cncr.30816","article-title":"Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: combined analyses of 2 prospective trials","volume":"123","author":"Tsujii","year":"2017","journal-title":"Cancer"},{"key":"15","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.ijrobp.2009.09.069","article-title":"Impact factors for microinvasion in intrahepatic cholangiocarcinoma: a possible system for defining clinical target volume","volume":"78","author":"Tan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","article-title":"Stereotactic body radiotherapy for unresectable cholangiocarcinoma","volume":"94","author":"H\u00f8yer","year":"2010","journal-title":"Radiother Oncol"},{"key":"17","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2000; 284:3043\u201345. https:\/\/doi.org\/10.1001\/jama.284.23.3043.","DOI":"10.1001\/jama.284.23.3043"},{"key":"18","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S0360-3016(00)00524-1","article-title":"Respiratory gated irradiation system for heavy-ion radiotherapy","volume":"47","author":"Kanazawa","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"19","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 2010. Available from URL: https:\/\/www.eortc.be\/services\/doc\/ctc\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf."},{"key":"20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:132::AID-CNCR28200301063.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Dawson","year":"2008","journal-title":"J Clin Oncol"},{"key":"22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3109\/0284186X.2011.652736","article-title":"Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors","volume":"51","author":"Fung","year":"2012","journal-title":"Acta Oncol"},{"key":"23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","article-title":"Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable intrahepatic cholangiocarcinoma: a retrospective dose response analysis","volume":"34","author":"Crane","year":"2016","journal-title":"J Clin Oncol"},{"key":"24","doi-asserted-by":"publisher","first-page":"93541","DOI":"10.18632\/oncotarget.19972","article-title":"Clinical outcomes and prognostic factors of stereotactic body radiation therapy for intrahepatic cholangiocarcinoma","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"25","first-page":"113","article-title":"Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients","volume":"12","author":"Tan","year":"2006","journal-title":"Cancer J"},{"key":"26","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/1471-2407-10-492","article-title":"Determining the role of external beam radiotherapy in unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 84 patients","volume":"10","author":"Tan","year":"2010","journal-title":"BMC Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1748-717X-8-292","article-title":"Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma","volume":"8","author":"Kim","year":"2013","journal-title":"Radiat Oncol"},{"key":"28","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1111\/jgh.12843","article-title":"Proton beam therapy for unresectable intrahepatic cholangiocarcinoma","volume":"30","author":"Sakurai","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"29","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Wolfgang","year":"2016","journal-title":"J Clin Oncol"},{"key":"30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ijrobp.2010.06.018","article-title":"Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma","volume":"81","author":"Czito","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T14:48:33Z","timestamp":1596725313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.27028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,8]]},"references-count":30,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2019,7,9]]}},"alternative-id":["27028","31320991"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.27028","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,8]]}}}